Cockroach Reduction Intervention for Childhood Asthma
(ARCHS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to help children with asthma by reducing cockroach exposure in their homes. Researchers will test two methods: a personalized approach based on each child's allergies (Comparator 1, tailored approach) and a simple, low-toxicity insecticidal bait (Comparator 2). The goal is to determine if these methods improve asthma symptoms, reduce doctor visits, and enhance quality of life. Children who frequently experience asthma symptoms or hospital visits, live in homes with cockroaches, and reside in the Greater New Orleans area might be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity to contribute to research that could improve asthma management for children.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, it mentions that children with asthma who are on long-term controller medication are eligible to participate, so it seems likely that continuing asthma medication is allowed.
What prior data suggests that this intervention is safe for children with asthma?
Research has shown that integrated pest management, which includes education, insecticide bait, and professional cleaning, effectively reduces cockroach numbers and allergens in homes. This method has improved health for children with asthma. Studies indicate it significantly lowers cockroach exposure and asthma symptoms over time.
Specifically, studies suggest that insecticide baits are generally safer for children than sprays or bombs. Baits are less likely to worsen asthma symptoms, which is crucial for children with asthma. However, limiting children's exposure to any pesticide is important to ensure their safety.
While this tailored approach and the use of insecticide bait have shown positive results, it is essential to follow safety guidelines to minimize any potential risks to children's health.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for childhood asthma because they focus on reducing cockroach allergens, which are a common trigger for asthma attacks. Unlike traditional asthma treatments that primarily focus on managing symptoms with inhalers or medication, these interventions aim to tackle the problem at its source. The tailored approach is unique because it uses a multi-component strategy customized to each child's allergic profile, potentially offering a more personalized and effective solution. Meanwhile, the use of insecticidal bait directly targets and reduces the cockroach population, which could significantly decrease allergen levels in the home environment. By addressing the root cause of asthma triggers, these treatments have the potential to improve long-term asthma management and quality of life for children.
What evidence suggests that this trial's treatments could be effective for childhood asthma?
This trial will compare two methods for reducing cockroach exposure to improve asthma symptoms in children. One group of participants will receive a tailored approach addressing a child's specific allergies, which studies have shown helps reduce asthma symptoms by lowering allergen levels in the home. Another group will use insecticidal bait, which research indicates effectively reduces the number of cockroaches in homes, leading to better asthma outcomes. Both methods aim to create a healthier living space for children with asthma by focusing on reducing key allergens like cockroach exposure.678910
Who Is on the Research Team?
Felicia Rabito, PhD
Principal Investigator
Tulane University School of Public Health and Tropical Medicine
Are You a Good Fit for This Trial?
The ARCHS trial is for children aged 5-17 in the Greater New Orleans area with uncontrolled persistent asthma and exposure to cockroaches. They must have had recent hospital visits or symptoms due to asthma, sleep at the target home most of the week, and speak English or Spanish. Kids can't join if they smoke, take beta-blockers, have certain heart diseases (except hypertension), other serious illnesses requiring daily meds, are on immunotherapy, or plan to move soon.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessment of asthma symptoms, quality of life, and cockroach exposure
Treatment
Participants receive either a multi-component intervention or insecticidal bait for cockroach reduction
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Comparator 1 (tailored approach)
- Comparator 2 (insecticidal bait)
Comparator 1 (tailored approach) is already approved in United States for the following indications:
- Asthma Management
- Allergy Prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
Patient-Centered Outcomes Research Institute
Collaborator